Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.

Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M.

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9349-54.

3.

Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.

Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M.

Cell Growth Differ. 1996 Feb;7(2):213-21.

4.

Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).

Tanaka K, Yamaguchi S, Sawano A, Shibuya M.

Jpn J Cancer Res. 1997 Sep;88(9):867-76.

PMID:
9369935
5.

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants.

Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Zioncheck TF, Pelletier N, Ferrara N.

J Biol Chem. 2001 Feb 2;276(5):3222-30. Epub 2000 Oct 31.

6.

Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.

Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S.

Princess Takamatsu Symp. 1994;24:162-70. Review.

PMID:
8983073
7.

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.

Fong GH, Rossant J, Gertsenstein M, Breitman ML.

Nature. 1995 Jul 6;376(6535):66-70.

PMID:
7596436
8.
9.

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW.

Nature. 1996 Apr 4;380(6573):439-42.

PMID:
8602242
13.

Blockade of in vivo VEGF-mediated angiogenesis by antisense gene therapy: role of Flk-1 and Flt-1 receptors.

Marchand GS, Noiseux N, Tanguay JF, Sirois MG.

Am J Physiol Heart Circ Physiol. 2002 Jan;282(1):H194-204.

14.

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.

Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Büttner M, Rziha HJ, Dehio C.

EMBO J. 1999 Jan 15;18(2):363-74.

16.
17.

KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF.

Li B, Ogasawara AK, Yang R, Wei W, He GW, Zioncheck TF, Bunting S, de Vos AM, Jin H.

Hypertension. 2002 Jun;39(6):1095-100.

18.
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk